Meta Pixel

News and Announcements

Anteo Signs Licensing Agreement

  • Published March 13, 2012 12:14AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

13th March 2012 Companys Announcement Office ASX Limited Exchange Centre 20 Bridge Street Sydney NSW 2000 Anteo signs licensing agreement with leading Life Science Company Agreement for the licensing of MixampGo technology with eBioscience Licensing arrangement for all global markets eBioscience operates in 70 countries and a recognised leader in Life Science reagents Agreement moves MixampGo up value chain to test manufacturers Healthy pipeline of potential commercial agreements 13 March 2012: Anteo Diagnostics Limited (ASX: ADO) is pleased to announce that it has signed a Patent and Technology License Agreement with eBioscience, a leading US headquartered Life Sciences company, providing them with access to Anteos unique MixampGo technology.

—–

To view the full article, please click here.

 

Company Updates
Dogs First to Reduce Risk: QBiotics’ Smarter Path to Oncology Markets

QBiotics took a compound derived from a north Queensland rainforest tree all the way to veterinary registration before pursuing human oncology to de-risk its human cancer programme. Interim CEO Ebru Davidson argues that sequence – now backed by early responses across several human cancers – is the company’s real asset. The story that pulled Wholesale […]

Company Updates
Built on discipline, not complexity: inside an ASX equities income strategy

Haydn Froggatt and Zac Brabin have decades of derivatives experience between them and access to almost any strategy in the market. They use two of the simplest structures available, and wrote 202 positions with them last year. Published by Fairway Capital Management. Based on an interview with co-founders Haydn Froggatt and Zac Brabin. Two traders, […]

Join over 45,000+ sophisticated investors

Join Now